Robbins Umeda LLP Is Investigating Animal Health International, Inc. Acquisition for Shareholders
Robbins Umeda LLP, a shareholder rights litigation firm, is investigating possible breaches of fiduciary duty and other violations of state law by members of the board of directors of Animal Health International, Inc. (NASDAQ: AHII) in connection with their efforts to sell Animal Health to privately held Lextron, Inc.
If you own stock in Animal Health and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
On March 14, 2011, Animal Health announced it has entered into a definitive merger agreement under which Lextron will acquire all of the outstanding common shares of Animal Health. Under the current agreement, Animal Health shareholders will receive $4.25 in cash for each share of Animal Health common stock they hold. The transaction is expected to close by June 30, 2011.
The investigation seeks to determine whether Animal Health’s board of directors is undertaking a fair process to obtain maximum value for its shareholders. Notably, at least one analyst has set a target price for Animal Health stock at $5.00 per share. Furthermore, on February 8, 2011, Animal Health reported strong sales figures of $198.2 million, compared to consensus estimates of $184.5 million.